CME Group Future Growth
Future criteria checks 1/6
CME Group is forecast to grow earnings and revenue by 3.4% and 4.3% per annum respectively. EPS is expected to grow by 3.4% per annum. Return on equity is forecast to be 12.9% in 3 years.
Key information
3.4%
Earnings growth rate
3.4%
EPS growth rate
Capital Markets earnings growth | 13.1% |
Revenue growth rate | 4.3% |
Future return on equity | 12.9% |
Analyst coverage | Good |
Last updated | 07 May 2024 |
Recent future growth updates
Recent updates
Gunning For CME's Golden Goose
May 01Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results
Apr 26CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty
Apr 15CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates
Mar 27CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Mar 05CME Group Is One Of My Favorite High-Yielding Stocks Today
Feb 29CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15
Feb 20CME Group: Buying 'The House' Proves A Winning Strategy
Feb 14CME Group: Uncertainty In The World Equals Higher Revenue Growth
Feb 04Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely
Dec 27Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors
Nov 14We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation
Apr 28CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year
Dec 15CME Group ADV climbs 21% Y/Y to 6.1M in Q3
Oct 11CME Group Is The Perfect Dividend Stock To Buy While It's Cheap
Sep 30CME Group launches ethereum options ahead of this week's blockchain Merge
Sep 12With EPS Growth And More, CME Group (NASDAQ:CME) Makes An Interesting Case
Sep 08CME Group proposes converting eurodollar futures, options contracts to SOFR
Sep 06CME Group launches bitcoin Euro and ether Euro futures
Aug 29CME Group set to launch ether futures options in September
Aug 18CME Group ADV perks up 20% in July in wake of volatile markets
Aug 02CME Q2 2022 Earnings Preview
Jul 26CME achieves 21% growth in Q2 international ADV
Jul 12CME Group average daily volume jumps to 24M contracts in June
Jul 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,491 | 3,653 | 3,984 | 4,069 | 8 |
12/31/2025 | 6,132 | 3,487 | 3,773 | 3,931 | 14 |
12/31/2024 | 5,918 | 3,448 | 3,745 | 3,812 | 14 |
3/31/2024 | 5,616 | 3,157 | 3,363 | 3,444 | N/A |
12/31/2023 | 5,569 | 3,186 | 3,377 | 3,454 | N/A |
9/30/2023 | 5,338 | 3,011 | 3,311 | 3,391 | N/A |
6/30/2023 | 5,228 | 2,942 | 3,108 | 3,192 | N/A |
3/31/2023 | 5,104 | 2,828 | 3,078 | 3,159 | N/A |
12/31/2022 | 5,009 | 2,657 | 2,966 | 3,056 | N/A |
9/30/2022 | 4,833 | 2,633 | 2,650 | 2,743 | N/A |
6/30/2022 | 4,715 | 2,889 | 2,616 | 2,717 | N/A |
3/31/2022 | 4,657 | 2,745 | 2,477 | 2,599 | N/A |
12/31/2021 | 4,690 | 2,617 | 2,275 | 2,402 | N/A |
9/30/2021 | 4,630 | 2,435 | 2,225 | 2,394 | N/A |
6/30/2021 | 4,600 | 1,920 | 1,888 | 2,074 | N/A |
3/31/2021 | 4,603 | 1,913 | 2,378 | 2,561 | N/A |
12/31/2020 | 4,884 | 2,105 | 2,518 | 2,716 | N/A |
9/30/2020 | 4,911 | 2,151 | 2,581 | 2,775 | N/A |
6/30/2020 | 5,109 | 2,375 | 3,071 | 3,274 | N/A |
3/31/2020 | 5,200 | 2,386 | 2,521 | 2,761 | N/A |
12/31/2019 | 4,868 | 2,117 | 2,427 | 2,673 | N/A |
9/30/2019 | 4,959 | 2,033 | 2,229 | 2,464 | N/A |
6/30/2019 | 4,588 | 1,808 | 2,027 | 2,236 | N/A |
3/31/2019 | 4,377 | 1,860 | 2,137 | 2,285 | N/A |
12/31/2018 | 4,309 | 1,962 | 2,324 | 2,441 | N/A |
9/30/2018 | 3,973 | 4,516 | 2,301 | 2,391 | N/A |
6/30/2018 | 3,959 | 4,413 | 2,242 | 2,316 | N/A |
3/31/2018 | 3,824 | 4,262 | 1,977 | 2,057 | N/A |
12/31/2017 | 3,645 | 4,063 | N/A | 1,751 | N/A |
9/30/2017 | 3,658 | 1,498 | N/A | 1,801 | N/A |
6/30/2017 | 3,609 | 1,662 | N/A | 1,773 | N/A |
3/31/2017 | 3,590 | 1,566 | N/A | 1,732 | N/A |
12/31/2016 | 3,595 | 1,534 | N/A | 1,732 | N/A |
9/30/2016 | 3,496 | 1,452 | N/A | 1,607 | N/A |
6/30/2016 | 3,505 | 1,340 | N/A | 1,591 | N/A |
3/31/2016 | 3,418 | 1,284 | N/A | 1,626 | N/A |
12/31/2015 | 3,327 | 1,247 | N/A | 1,533 | N/A |
9/30/2015 | 3,354 | 1,262 | N/A | 1,644 | N/A |
6/30/2015 | 3,266 | 1,192 | N/A | 1,414 | N/A |
3/31/2015 | 3,178 | 1,191 | N/A | 1,327 | N/A |
12/31/2014 | 3,113 | 1,127 | N/A | 1,291 | N/A |
9/30/2014 | 2,958 | 1,014 | N/A | 1,171 | N/A |
6/30/2014 | 2,911 | 960 | N/A | 1,066 | N/A |
3/31/2014 | 2,990 | 1,008 | N/A | 1,268 | N/A |
12/31/2013 | 2,931 | 977 | N/A | 1,281 | N/A |
9/30/2013 | 2,905 | 951 | N/A | 1,221 | N/A |
6/30/2013 | 2,874 | 932 | N/A | 1,331 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CME's forecast earnings growth (3.4% per year) is above the savings rate (2.4%).
Earnings vs Market: CME's earnings (3.4% per year) are forecast to grow slower than the US market (14.6% per year).
High Growth Earnings: CME's earnings are forecast to grow, but not significantly.
Revenue vs Market: CME's revenue (4.3% per year) is forecast to grow slower than the US market (8.4% per year).
High Growth Revenue: CME's revenue (4.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CME's Return on Equity is forecast to be low in 3 years time (12.9%).